Literature DB >> 17990485

Leveraging latent information in NMR spectra for robust predictive models.

David Chang1, Aalim Weljie, Jack Newton.   

Abstract

A significant challenge in metabolomics experiments is extracting biologically meaningful data from complex spectral information. In this paper we compare two techniques for representing 1D NMR spectra: "Spectral Binning" and "Targeted Profiling". We use simulated 1D NMR spectra with specific characteristics to assess the quality of predictive multivariate statistical models built using both data representations. We also assess the effect of different variable scaling techniques on the two data representations. We demonstrate that models built using Targeted Profiling are not only more interpretable than Spectral Binning models, but are more robust with respect to compound overlap, and variability in solution conditions (such as pH and ionic strength). Our findings from the synthetic dataset were validated using a real-world dataset.

Mesh:

Year:  2007        PMID: 17990485

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  9 in total

1.  Malignancy prediction among tissues from Oral SCC patients including neck invasions: a 1H HRMAS NMR based metabolomic study.

Authors:  Anup Paul; Shatakshi Srivastava; Raja Roy; Akshay Anand; Kushagra Gaurav; Nuzhat Husain; Sudha Jain; Abhinav A Sonkar
Journal:  Metabolomics       Date:  2020-03-11       Impact factor: 4.290

2.  Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.

Authors:  Pascal Mercier; Michael J Lewis; David Chang; David Baker; David S Wishart
Journal:  J Biomol NMR       Date:  2011-03-01       Impact factor: 2.835

3.  (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system.

Authors:  Aalim M Weljie; Alla Bondareva; Ping Zang; Frank R Jirik
Journal:  J Biomol NMR       Date:  2011-03-04       Impact factor: 2.835

4.  Altered Metabolomics in Bipolar Depression With Gastrointestinal Symptoms.

Authors:  Xiang-Jie Guo; Yan-Bing Xiong; Yuan Jia; Xiao-Hong Cui; Wen-Ze Wu; Jun-Sheng Tian; Hong Yang; Yan Ren
Journal:  Front Psychiatry       Date:  2022-05-24       Impact factor: 5.435

5.  Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.

Authors:  Jaehyup Kim; Melissa J Breunig; Leah E Escalante; Neehar Bhatia; Ryan A Denu; Bridget A Dollar; Andrew P Stein; Summer E Hanson; Nadia Naderi; James Radek; Dermot Haughy; Debra D Bloom; Fariba M Assadi-Porter; Peiman Hematti
Journal:  Cytotherapy       Date:  2012-05-09       Impact factor: 5.414

6.  NMR Spectroscopy-Based Metabolic Profiling of Biospecimens.

Authors:  Arjun Sengupta; Aalim M Weljie
Journal:  Curr Protoc Protein Sci       Date:  2019-12

7.  Isolation, Characterization and Chemical Synthesis of Large Spectrum Antimicrobial Cyclic Dipeptide (l-leu-l-pro) from Streptomyces misionensisV16R3Y1 Bacteria Extracts. A Novel 1H NMR Metabolomic Approach.

Authors:  Ilhem Saadouli; Imène Zendah El Euch; Emna Trabelsi; Amor Mosbah; Alaeddine Redissi; Raoudha Ferjani; Imene Fhoula; Ameur Cherif; Jean-Marc Sabatier; Norbert Sewald; Hadda-Imene Ouzari
Journal:  Antibiotics (Basel)       Date:  2020-05-21

8.  The Metabolomic Rationale for Treating Perimenopausal Syndrome as Kidney Deficiency.

Authors:  Xueqin Chen; Caiming Wu; Wen'na Liang; Jianying Shen; Zewei Zhuo; Liu Hu; Luwei Ruan; Pengheng Zhang; Leqin Xu; Chengfu Li; Shengyuan Lin; Junjie Lan; Haixia Ren; Hongwei Yao; Tongjin Zhao; Bizhen Gao; Tianwei Lin; Huiying Huang; Candong Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-09       Impact factor: 2.629

9.  Revealing Potential Biomarkers of Functional Dyspepsia by Combining 1H NMR Metabonomics Techniques and an Integrative Multi-objective Optimization Method.

Authors:  Qiaofeng Wu; Meng Zou; Mingxiao Yang; Siyuan Zhou; Xianzhong Yan; Bo Sun; Yong Wang; Shyang Chang; Yong Tang; Fanrong Liang; Shuguang Yu
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.